Gen1 Research

Gen1 Research is a clinical research service company founded in 2017. The company's slogan, "Better care. It's necessary, and it's possible," reflects its focus on improving health care through clinical research. Gen1 Research operates in the Biotechnology and Health Care industries, positioning itself at the intersection of innovation and patient care. The core offering of Gen1 Research is its Clinical Trial Management System (CTMS), Helix, which serves as a comprehensive platform to facilitate all stages of clinical trials. This includes patient identification, qualification, site activation, patient enrollment, study initiation, and study conclusion. The company has positioned itself as a facilitator, providing personnel, processes, technology, and infrastructure essential for physicians to conduct research within their own clinics. Although specific information about the company's headquarters, last investment, and investors is not available, the value proposition of Gen1 Research lies in its potential to streamline and simplify the clinical research process. By connecting physicians and patients with relevant clinical trials, Gen1 Research aims to accelerate the pace of medical innovation and improve patient outcomes. In summary, Gen1 Research aims to carve a niche in the clinical research services sector by offering a comprehensive solution that empowers physicians to engage in research within their own establishments, contributing to the advancement of medical knowledge and the enhancement of patient care.